Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.065 | 0.7 |